English Journal

From insulin and insulin-like activity to the insulin superfamily of growth-promoting peptides: a 20th-century odyssey.

Blumenthal S.Author information Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA. sblument@uic.eduAbstractIn 1941, Gellhorn reported that administration of human blood to hypophysectomized/adrenodemedullated rats caused a fall in blood sugar. This was among the early demonstrations that human blood possesses glucose-lowering or insulin-like activity (ILA). Gellhorn assumed he had detected only insulin. During the 1960s, however, it became evident that plasma ILA contained at least two components: one, suppressible ILA (SILA), was inactivated by anti-insulin antibody and was therefore considered to be indistinguishable from pancreatic insulin; the other, nonsuppressible ILA (NSILA), was unaffected by anti-insulin antibody. Subsequent work resolved NSILA into insulin-like growth factors I and II (IGF-I and IGF-II), two 7.5 kilodalton peptides with potent mitogenic properties; established their identity with the somatomedins; and investigated both their therapeutic potential and role in the pathogenesis of neoplastic and other human diseases. Insulin and the IGFs exhibit striking homologies in amino acid composition and some degree of overlap in their signaling pathways and actions. Moreover, insulin-like proteins have been identified not only in all vertebrate classes but also in molluscs, insects, and worms. These observations are the basis for the hypothesis that the genes encoding vertebrate insulins and IGFs and invertebrate insulin-like molecules evolved from a common ancestral gene, and for the concept of an insulin superfamily of growth-promoting peptides.
Perspectives in biology and medicine.Perspect Biol Med.2010 Autumn;53(4):491-508. doi: 10.1353/pbm.2010.0001.
In 1941, Gellhorn reported that administration of human blood to hypophysectomized/adrenodemedullated rats caused a fall in blood sugar. This was among the early demonstrations that human blood possesses glucose-lowering or insulin-like activity (ILA). Gellhorn assumed he had detected only insulin.
PMID 21037404

A personal view on the early history of the insulin-like growth factors.

Van den Brande JL.Author information leo_van_den_brande@wxs.nlAbstractSalmon and Daughaday, when trying to set up an in vitro assay for Growth Hormone (GH), failed to obtain a direct effect on sulphate uptake in cartilage of hypophysectomized (hypox) rats. They recognised that this was not the consequence of poor methodology or materials, but an encrypted message from the examined system. They decided to turn around and to try and decipher it. Treatment with GH appeared to render hypox rat serum active in stimulating sulphation in hypox rat cartilage. They proposed that GH induced an intermediary substance, responsible for this biological effect: sulphation factor (SF), later renamed to Somatomedin(s) (SM). This hypothesis met with great criticism and very few took on to study this hypothetical substance. Besides disbelief, slow progress was also due to initial lack of a practical assay and to the failure to find a tissue with enriched concentration from which to extract the activity. From experimental evidence, the concept gradually evolved that SF/SM was insulin-like and might be identical to NSILA (non-suppressible insulin-like activity). This again generated controversy. This characteristic was too far away from the known effects of GH to be readily acceptable as a physiological phenomenon. The subsequent recognition of the distinct characteristics of the receptors for SM/NSILA and insulin, the discovery of the SM/NSILA binding proteins and, much later, a beginning understanding of their interactions, modifications and breakdown, have gradually resolved this apparent contradiction. When the sequence of two NSILA molecules became known, they were named IGF-I and -II. Structural similarity with proinsulin and identity of IGF-I with SM-C and -A were established and it was found that Multiplication Stimulating Activity (MSA), a growth factor isolated from fetal calf serum and subsequently from conditioned media of a rat liver cell line, was the rat equivalent of IGF-II. Structure-function relations could be studied, a quest which is not yet brought to an end. Meanwhile, the endocrine profile of SF/SM had gradually emerged by measuring plasma levels with bioassays. The main determinants were found to be age, body size, GH and the nutritional state. Later, radioimmunoassays were developed, enabling consolidation and detailing of these early observations, and allowing explorations at the tissue level. As another aspect of the endocrine paradigm, in vivo effects of IGFs were studied. The initial demonstration of an effect of crude preparations on longitudinal growth in experimental animals raised heavy scepticism, since the effect might have been an artefact caused by contaminants. It took confirmation with highly purified preparations and biosynthetic IGF-I to ease this concern. Still, not until recent years it was demonstrated, by knocking out the genes, that a true physiological and not a pharmacological effect had been induced previously. When it was found that most tissues produce SMs and are sensitive to their actions, the concept emerged that IGFs may have para- and autocrine functions. Early experiments with combinations of growth factors in cell cultures had begun to define their specific roles in the cell cycle as competence or progression factors. SM-C fell in the latter category. Still, the awareness grew that, for obtaining physiologically meaningful results on the role of IGFs in complex, dynamic and tissue-specific environments, involving interactions of many hormones and growth factors, the intactness of tissue was a prerequisite. One result of this approach was the discovery of a direct interaction of GH with cartilage, leading, in concert with IGFs, to a clonal expansion of the cartilage cells of the growth plate. The isolation and sequencing of the IGF-I and -II genes, and later, of six IFG-BPs initiated the gradual elucidation of structure and function at the DNA and RNA level and the study of natural and synthetic IGF-variants. The generation of transgenic animals became feasible
Hormone research.Horm Res.1999;51 Suppl 3:149-75.
Salmon and Daughaday, when trying to set up an in vitro assay for Growth Hormone (GH), failed to obtain a direct effect on sulphate uptake in cartilage of hypophysectomized (hypox) rats. They recognised that this was not the consequence of poor methodology or materials, but an encrypted message from
PMID 10592460

New concepts in insulin-like growth factor receptor physiology.

Oh Y1, Müller HL, Neely EK, Lamson G, Rosenfeld RG.
Growth regulation.Growth Regul.1993 Jun;3(2):113-23.
PMID 8339044

Japanese Journal

Non Suppressible Insulin Like Activity(NSILA-S)の粗精製とインスリンレセプタ-アッセイによる測定法の確立

尾崎史郎,門田悟,中川昌一
糖尿病 23(10), p923-929, 1980-10
NAID 40002631444

Non Suppressible Insulin Like Activity (NSILA-s) の粗精製とインスリンレセプターアッセイによる測定法の確立

尾崎史郎,門田悟,中川昌一
糖尿病 23(10), 923-929, 1980
… インスリン様物質 (NSILA-s) が血清中より精製され, その測定にはbioassayのかわりにradioreceptor assay (RRA) が開発されている.今回我々はNSILA-sの類似物質であるsomatomedin Cがヒト胎盤細胞膜のインスリンレセプターと結合し, インスリンと拮抗する性質を有することより, ヒト胎盤細胞膜より可溶化したインスリンレセプターを使用し, レセプターアッセイを行い, NSILA-sの測定法を開発し …
NAID 130004336811

A-1. ラジオリセプターアッセーによる血中NSILAの純化とその測定

佐々木憲夫,今井康雄,松崎宸,小坂樹徳,対馬敏夫
臨床化学シンポジウム 18(0), 2-6, 1979
… Insulin-like growth factor (IGF) is the genoric designation for serum polypeptides such as somatomedins, multiplication stimulating activity (MSA), and non suppressible insulin-like activity (NSILA), which possess both insulin-like activity and cell growth promoting activity. …
NAID 130003355262

Related Pictures

Susani Nsila - Big L Inghilterra, grave infortunio per Berry Insila Ka Lova – Ingakith’ La (prod. by MasterDee) | Free Download | The Shelf Of Nsila ka Lova – Oops Tape | Free Download | The Shelf Of Real HipHop ARURRU NKANGA LA NSILA - YouTube Xhensila Myrtezaj surprizon të gjithë me foton e fundit në Instagram, si ia doli 301 Moved Permanently Raissa Ngunga Nsila - CV - Presse écrite